Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Photoimmunotherapy - 09/04/2026 Zu sehen ist in einer Fluoreszenz-Aufnahme unter dem Mikroskop runde Ansammlungen in blauer Farbe, die die Zellkerne darstellen und rote Signale dicht daneben, die die Konjugate darstellen, all´ das vor schwarzem Hintergrund.

    Switching off tumours with light: how photons can be used to target prostate cancer

    Prostate cancer is the most common cancer among men in Germany. Relapses and the harsh side effects of traditional treatments remain a major challenge, even with advanced surgical techniques. At the University of Freiburg, Dr. Wolf is pioneering the development of photoimmunotherapy. Photoimmunotherapy combines light, antibodies and a specialised dye to precisely target tumour cells - simultaneously 'waking up' the immune system.

    https://www.gesundheitsindustrie-bw.de/en/article/news/switching-tumours-light-how-photons-can-be-used-target-prostate-cancer
  • Press release - 07/04/2026

    No soft drink before the massage

    How does sugar affect relaxation exercises? A new study carried out by researchers from the University of Konstanz provides revealing insights into the connection between blood glucose and the autonomic nervous system: The intake of sugar counteracts relaxation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/no-soft-drink-massage
  • Press release - 07/04/2026

    The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase

    Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology, HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation and machine learning.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-booster-evolves-simplaix-collaboration-starts-next-phase
  • Press release - 07/04/2026

    The molecular research “booster” evolves: SIMPLAIX collaboration starts the next phase

    Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology, HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation and machine learning.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-research-booster-evolves-simplaix-collaboration-starts-next-phase
  • Press release - 01/04/2026

    Digital Assistance System Designed to Prevent Recurrent Heart Disease

    Women who have experienced a stroke or heart attack are at a higher risk of mortality than men. Fraunhofer researchers want to improve gender-specific aftercare with a customized assistance system – thus helping to prevent further heart disease.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-assistance-system-designed-prevent-recurrent-heart-disease
  • Press release - 31/03/2026

    First steps towards cell therapy for brain disorders

    Researchers in Freiburg have found a way to selectively replace defective immune cells in the blood vessels of the brain using an animal model. This is an important first step towards cell therapies for Alzheimer’s disease and other brain disorders. The findings were recently published in the journal Nature Immunology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/first-steps-towards-cell-therapy-brain-disorders
  • Press release - 30/03/2026

    Ulm University funds projects on molecular quantum bits and digital diabetes research Research incubators focus on ideas outside the mainstream

    Creating scope for innovative projects from various disciplines: That is the aim of the research incubators at Ulm University. The aim is to initiate developments and ideas that could become relevant research areas for the University. In the current call for proposals, the jury has selected two interdisciplinary projects on quantum chemistry and digital, sensor-based diabetes research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ulm-university-funds-projects-molecular-quantum-bits-and-digital-diabetes-research-research-incubators-focus-ideas-outside-mains
  • Proof-of-concept study of organoid technology - 26/03/2026 Smiling man with glasses wearing a white lab coat.

    Can organoids improve the treatment of pancreatic cancer?

    A clinical trial called UNITEPANC is exploring whether organoid-based approaches can improve the treatment of pancreatic cancer. BIOPRO Baden-Württemberg spoke with the study’s principal investigator and pancreatic cancer specialist, Prof. Dr. Thomas Seufferlein of University Hospital Ulm, to discuss the disease more broadly along with the specific aims of the trial. The interview was conducted by Walter Pytlik on behalf of BIOPRO.

    https://www.gesundheitsindustrie-bw.de/en/article/news/can-organoids-improve-treatment-pancreatic-cancer
  • Press release - 25/03/2026

    The Influence of Lymph Node Architecture on Lymphoma

    For the first time, researchers have succeeded in mapping the organization of immune cells in human lymph nodes. The study was led by scientists from Heinrich Heine University Düsseldorf, Düsseldorf University Hospital, the DKFZ, the European Molecular Biology Laboratory (EMBL), and the Max Delbrück Center (MDC) in Berlin. They were able to demonstrate why the architecture of healthy lymph nodes is altered in malignant lymphomas.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/influence-lymph-node-architecture-lymphoma
  • Press release - 23/03/2026

    Aggravated neuroimmune response, delayed wound healing Transcription factor NF-κB in astrocytes critically affects the outcome of traumatic brain injury (TBI)

    Traumatic brain injuries often lead to complications with long-lasting consequences on memory, concentration and movement control. Detrimental secondary inflammatory reactions at the injured tissue sites are often responsible for this. Researchers from Ulm have now shown that a transcription factor plays a key role in reactions to TBI. When this gene regulator is activated, an elevated neuroimmune response promotes inflammation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/aggravated-neuroimmune-response-delayed-wound-healing-transcription-factor-nf-kb-astrocytes-critically-affects-outcome-traumatic
  • Press release - 23/03/2026

    After a Heart Attack: Inflammation Weakens the Heart’s Energy Production

    Why does heart function often continue to deteriorate after a heart attack, even though blood flow has been restored? A research team from the DZHK sites Heidelberg and North has now identified an important mechanism: an inflammatory switch in cardiomyocytes can impair cellular energy production and thereby drive the development of heart failure. The results were published in Nature Communications.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/after-heart-attack-inflammation-weakens-hearts-energy-production
  • Press release - 23/03/2026

    New findings on the first steps in Protein Synthesis

    In the earliest phase of creating human proteins, the protein complex NAC performs an essential task by starting the first steps towards folding proteins into their correct three-dimensional structures. This discovery was made by an international research team led by scientists from the Center for Molecular Biology of Heidelberg University.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-first-steps-protein-synthesis
  • Press release - 19/03/2026

    How old are we really?

    Ageing is a highly individual process. An international consortium coordinated by researchers in Konstanz has developed a method that uses biomarkers to determine a person's biological age – a valuable tool for research on ageing and the development of new approaches in preventive medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-old-are-we-really
  • Press release - 12/03/2026

    Brain Diseases: Certain Neurons Are Especially Susceptible to ALS and FTD

    Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms. Many patients have a common hallmark: A protein called TDP-43 clumps together in the neurons of the brain to form tiny lumps. Researchers at DZNE and Ulm University Hospital, together with international experts, have now discovered that these pathological changes primarily affect certain cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-diseases-certain-neurons-are-especially-susceptible-als-and-ftd
  • Press release - 11/03/2026

    Blood Marker for Alzheimer’s May also Be Useful in Heart and Kidney Diseases

    A certain blood protein regarded as an early indicator of Alzheimer’s disease also appears to play a role in other disorders. Researchers at DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen have found that elevated levels of phosphorylated tau protein (pTau) also occur in two lesser-known conditions that primarily affect the heart and kidneys.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-marker-alzheimers-may-also-be-useful-heart-and-kidney-diseases
  • Press release - 10/03/2026

    Advanced melanoma: Antibodies in the blood indicate side effects of immunotherapy

    Immunotherapies have greatly improved the treatment of metastatic melanoma, but they can cause serious side effects. A study led by researchers from Heidelberg University's Medical Faculty, the Heidelberg University Hospital, and the NCT in Heidelberg now shows that autoantibodies detected in the blood before the start of therapy could help to better assess the individual risk of side effects in patients.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/advanced-melanoma-antibodies-blood-indicate-side-effects-immunotherapy
  • Press release - 04/03/2026

    Thermogenetics: How Proteins are controllable by heat

    Protein activity can be precisely regulated via subtle changes in temperature using heat-sensitive switches. Underlying this capability is a novel modular design strategy developed by researchers at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University. The strategy allows the integration of sensory domains in various proteins regardless of function or spatial structure.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/thermogenetics-how-proteins-are-controllable-heat
  • Press release - 03/03/2026

    AI Chip Design From Heilbronn

    AI plays a huge role in the semiconductor industry, both by facilitating more efficient development processes and as a target application in development work. This is why the Fraunhofer Heilbronn Research and Innovation Centers HNFIZ are adding the Chip AI research and innovation center for AI chip design to their service range. The center is funded via the Dieter Schwarz Foundation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-chip-design-heilbronn
  • Press release - 02/03/2026

    Novel therapy for Phelan-McDermid syndrome Drug development to be funded with up to 1.7 million euros

    An international team led by Professor Tobias M. Böckers from Ulm University Medical Centre has been awarded up to 1.7 million euros to develop a novel therapy for a rare, syndromic form of autism. The research project focuses on a gene whose loss of function can manifest itself in severe impairments in language, behaviour and everyday functions of those affected.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-therapy-phelan-mcdermid-syndrome-drug-development-be-funded-17-million-euros
  • Press release - 26/02/2026

    Mitochondria influence lipid storage in cells

    The powerhouse of the cells, known as mitochondria, appear to be able to influence the number of lipid droplets in the cell. Research into this previously unknown mechanism was conducted using baker’s yeast. This is shown by a recent study by the University of Freiburg, the University of Bonn and the University Hospital Bonn and the University of Freiburg. The results have now been published in the journal Nature Cell Biology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mitochondria-influence-lipid-storage-cells
  • Press release - 25/02/2026

    Magnetic Microrobot Swarms Enable Contactless Manipulation of Objects Through Fluidic Torque

    In a study, a team of researchers show that groups of magnetic microrobots can generate fluidic forces strong enough to rotate objects in different directions without touching them. These microrobot swarms can turn gear systems, rotate objects much larger than the robots themselves, assemble structures on their own, and even pull in or push away many small objects. The work was now published in Science Advances.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/magnetic-microrobot-swarms-enable-contactless-manipulation-objects-through-fluidic-torque
  • Press release - 18/02/2026

    New centre for cell research

    Technology impulse for the Lake Constance region: The new Single Cell Centre at the University of Konstanz offers technology and expertise to study cells individually and at high resolution – for applications in medical diagnostics, medication development and basic research at universities.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-centre-cell-research
  • Press release - 18/02/2026

    Shingles vaccination could slow cognitive decline

    New findings indicate that a shingles vaccination could not only reduce the risk of cognitive impairment and dementia, but also reduce disease progression among those living with dementia.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/shingles-vaccination-could-slow-cognitive-decline
  • Press release - 17/02/2026

    Tracing Tumors in Cerebrospinal Fluid: A New Opportunity for Precision Diagnostics in Brain Tumors

    In a published scientific study, researchers have succeeded in accurately diagnosing common types of brain tumors in children and adolescents based on tumor-derived genetic material in cerebrospinal fluid. Until now, these so-called liquid biopsies were not capable enough for such reliable diagnostics. The international research team has therefore optimized a sequencing technique and developed an AI-based computational method. In a later step,…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tracing-tumors-cerebrospinal-fluid-new-opportunity-precision-diagnostics-brain-tumors
  • Press release - 13/02/2026

    Molecular cause of radiation damage identified

    A severe side effect of radiation therapy can be debilitating fibrotic skin damage. Scientists at the German Cancer Research Center (DKFZ) have now identified a key factor in the development of this radiation damage. Modulating this factor could potentially prevent this severe adverse effect.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-cause-radiation-damage-identified

Page 1 / 21

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 21
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2026
Website address: https://www.gesundheitsindustrie-bw.de/en/search